Xtandi

Active Ingredient(s): Enzalutamide
FDA Approved: * August 31, 2012
Pharm Company: * MEDIVATION
Category: Cancer

Enzalutamide, sold under the brand name Xtandi, is a nonsteroidal antiandrogen (NSAA) medication which is used in the treatment of prostate cancer.[2][6] It is indicated for use in conjunction with castration in the treatment of metastatic castration-resistant prostate cancer (mCRPC),[2] nonmetastatic castration-resistant prostate cancer,[2] and metastatic castration-sensitive prostate cancer (mCSPC).[7] It is ta... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
4 Discussions

Dosage List

Xtandi MDV
Xtandi 40 mg Oral Capsule
NDC: 0469-0125
Labeler:
Astellas Pharma Us, Inc.
Xtandi 40 mg Oral Tablet
NDC: 0469-0625
Labeler:
Astellas Pharma Us, Inc.
Xtandi 80 mg Oral Tablet
NDC: 0469-0725
Labeler:
Astellas Pharma Us, Inc.
Xtandi 40 mg Oral Capsule
NDC: 0469-1125
Labeler:
Astellas Pharma Us, Inc.
Xtandi 40 mg Oral Tablet
NDC: 0469-1725
Labeler:
Astellas Pharma Us, Inc.

Popular Topics

Xtandi and other treatments

My husband has an aggressive form of prostate cancer. In 2 years have been through chemo, radiation, lupron, immunothera...

2 REPLIES